Cargando…
Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity
BACKGROUND: Previous evidence demonstrated that restoration of wild type VHL in human renal cancer cells decreased in vitro NK susceptibility. To investigate on the role of tumoral VHL status versus NK capability in renal cancer patients, 51 RCC patients were characterized for VHL mutational status...
Autores principales: | Trotta, Anna Maria, Santagata, Sara, Zanotta, Serena, D’Alterio, Crescenzo, Napolitano, Maria, Rea, Giuseppina, Camerlingo, Rosa, Esposito, Fabio, Lamantia, Elvira, Anniciello, Annamaria, Botti, Giovanni, Longo, Nicola, Botti, Gerardo, Pignata, Sandro, Perdonà, Sisto, Scala, Stefania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278085/ https://www.ncbi.nlm.nih.gov/pubmed/30514329 http://dx.doi.org/10.1186/s13046-018-0952-7 |
Ejemplares similares
-
CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells
por: Ieranò, Caterina, et al.
Publicado: (2019) -
Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer
por: Santagata, Sara, et al.
Publicado: (2017) -
Variability in Immunohistochemical Detection of Programmed Death Ligand 1 (PD-L1) in Cancer Tissue Types
por: Scognamiglio, Giosuè, et al.
Publicado: (2016) -
Von Hippel-Lindau Disease
por: Hes, Frederik J, et al.
Publicado: (2005) -
New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer
por: D’Alterio, Crescenzo, et al.
Publicado: (2020)